QT Prolongation Risks with Ribociclib and Tamoxifen

This chapter highlights the overlooked risks of QT prolongation when ribociclib is used in conjunction with tamoxifen. It discusses findings from the MONALEESA-7 study and underscores the need for healthcare practitioners to be aware of potential drug interactions to ensure patient safety.